| Overview |
| bsm-62241r-Cy5.5-100ul |
| GLK Recombinant Antibody, Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human GCK |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 2645 |
| P35557 |
| Cytoplasm, Nucleus |
| GCK; GK; GLK; Glucokinase; HHF3; HK IV; HK4; HKIV; HXKP; LGLK; MODY2. |
| Catalyzes the initial step in utilization of glucose by the beta-cell and liver at physiological glucose concentration. Glucokinase has a high Km for glucose, and so it is effective only when glucose is abundant. The role of GCK is to provide G6P for the synthesis of glycogen. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz